EXECUTIVE DIRECTOR OF BIOSTATISTICS, HEAD OF DESIGN & INNOVATION, AMGEN
Newbury Park, California, United States
May Mo is an Executive Director of Biostatistics at Amgen. She is the Head of Design and Innovation (D&I) group in the Center for Design and Analysis, and the Chair of Innovative Clinical Trial Design Council within Amgen Global Development. In her roles, May has been a strong advocate and enabler of innovative approaches in clinical development planning and clinical trial design. May has over 20 years of drug and device development experience in Amgen and Abbott laboratory.
1:45 PM - 2:45 PM (PDT)
Tuesday, June 14
Complex Innovative Design - What’s in a Name? A Global Perspective on the Changing Design Landscape for Clinical Trials and What That Means for Developers
Complex Innovative Design – what’s in a name? A global perspective on the changing…